版本:
中国

BRIEF-Voyager Therapeutics Q4 gaap loss per share $0.57

March 15 Voyager Therapeutics Inc

* Voyager therapeutics reports fourth quarter and full year 2016 financial results and corporate highlights

* Q4 gaap loss per share $0.57

* Q4 earnings per share view $-0.46 -- Thomson Reuters I/B/E/S

* Voyager therapeutics inc - collaboration revenues of $2.4 million for q4 of 2016 compared to collaboration revenues of $4.9 million for q4 of 2015 Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐